Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part 2. Tumorigenic cell lines

Prostate

Volumn 30, Issue 1, 1997, Pages 58-64

  Webber, Mukta M ^a   Bello, Diana ^a   Quader, Salmaan ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

androgen receptor; growth factor receptors; growth factors; human papillomavirus; prostate cancer; prostate specific antigen; ras oncogene; tumorigenic cell lines

Indexed keywords

ANDROGEN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 8; CYTOKERATIN; DESMIN; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; CANCER CELL CULTURE; CARCINOGENESIS; CELL IMMORTALIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; ONCOGENE RAS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; REVIEW; SIMIAN VIRUS 40; WART VIRUS;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARCINOMA; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; GLUTAMATE CARBOXYPEPTIDASE II; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; PAPILLOMAVIRIDAE; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TUMOR CELLS, CULTURED;

EID: 0031036928     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970101)30:1<58::AID-PROS9>3.0.CO;2-H     Document Type: Review

References (46)

1. Webber MM, Bello D, Quader S: Immortalized and tumorigenic adult human prostate epithelial cell lines: Characteristics and applications. Part 1. Cell markers and immortalized non-tumorigenic cell lines. Prostate 29:386-394, 1996.
2. Webber MM: In vitro models for prostate cancer: Summary. In Murphy GP (ed): "Models for Prostate Cancer." Progr in Clinical Biol Res 37:133-147, 1980.
3. Leong SS, Horoszewicz JS: In vitro models for human prostatic cancer: Cell lines of human prostatic carcinoma. In Webber MM, Sekely LI (eds): "In Vitro Models for Cancer Research. Carcinoma of the Prostate and Testis," Vol V. Boca Raton, FL: CRC Press, 1988, pp 127-137.
4. Mickey DD, Stone KR, Wunderli H, Mickey G, Paulson DF: Characterization of a human prostate adenocarcinoma cell line (DU-145) as a monolayer culture and a solid tumor in athymic mice. In Murphy GP (ed): "Models for Prostate Cancer." Progr in Clinical Biol Res 37:67-84, 1980.
5. Brolin J, Skoog L, Ekman P: Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate 20:281-295, 1992.
6. Castagnetta L, Carruba G, Granata OM, Lo Casto M, Arcuri F, Mesiti M, Pavone-Macaluso M: Prostate longterm epithelial cell lines: Biological and biochemical features. Ann NY Acad Sci 595:149-164, 1990.
7. Katsuoka Y, Hoshino H, Shiramizu M, Sakabe K, Seiki K: Autoradiographic and cytochemical localization of androgen in human prostatic cancer cell lines. Invest Urol 28:228-231, 1986.
8. Kaighn ME, Narayan S, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23, 1979.
9. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF: Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 21:274-281, 1978.
10. Carruba G, Leake RE, Rinaldi F, Chalmers D, Comito L, Sorci C, Pavone-Macaluso M, Castagnetta LAM: Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells. Steroids 59:412-420, 1994.
11. Tillotson JK, Rose DP: Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells. Cancer Lett 60:109-112, 1991.
12. Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M, Dodd JG: Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126:151-158, 1993.
13. Nakamoto T, Chang C, Li A, Chodak GW: Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 52:571-577, 1992.
14. Keer HN, Kozlowski JN, Tsai YC, Lee C, McEwan RN, Grayhack JT: Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J Urol 143:381-385, 1990.
15. Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D, Baserga R: Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res 53:1102-1106, 1993.
16. Wilding G, Zugmeir G, Knabbe C, Flanders K, Gelmann E: Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol Cell Endocrinol 62:79-87, 1989.
17. Garde SV, Sheth AR, Porter AT, Pienta KJ: A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett 70:159-166, 1993.
18. Rossi MC, Zetter BR: Selective stimulation of prostatic carcinoma cell proliferation by transferrin. Proc Natl Acad Sci USA 89:6197-6201, 1992.
19. Carruba G, Pfeffer U, Fecarotta E, Coviello DA, D'Amato E, Casto ML, Vidali G, Castagnetta L: Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells. Cancer Res 54:1190-1193, 1994.
20. Franzen P, Ichijo H, Miyazono K: Different signals mediate transforming growth factor-β1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp Cell Res 207:1-7, 1993.
21. Hsieh J, Luo W, Song W, Wang Y, Kleinerman DI, Van NT, Lin S: Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res 55:190-197, 1995.
22. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA: The LNCaP cell line - A new model for studies on human prostatic carcinoma. In Murphy GP (ed): "Models for Prostate Cancer." Progr in Clinical Biol Res 37:115-132, 1980.
23. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818, 1983.
24. Berns EMJJ, de Boer W, Mulder E: Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate rumor cell line LNCaP. Prostate 9:247-259, 1986.
25. Langeler EG, van Uffelen CJC, Blankenstein MA, van Steenbrugge GJ, Mulder E: Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP. Prostate 23:213-223, 1993.
26. Webber MM, Waghray A, Bello D: Prostate specific antigen (PSA), a serine protease, facilitates human prostate cancer invasion. Clin Cancer Res 1:1089-1094, 1995.
27. Schuurmans AL, Bolt J, Veldscholte J, Mulder E: Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 40:193-197, 1991.
28. Connolly JM, Rose DP: Production of epidermal growth factor and transforming growth factor-α by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16:209-218, 1990.
29. Iwamura M, Sluss PM, Casamento JB, Cockett ATK: Insulin-like growth factor 1: Action and receptor characterization in human prostate cancer cell lines. Prostate 22:243-252, 1993.
30. Iizumi T, Yazaki T, Kanoh S, Kondo I, Koiso K: Establishment of a new prostatic carcinoma cell line (TSU-PR1). J Urol 137:1304-1306, 1987.
31. Carter BS, Epstein JI, Isaacs WB: ras gene mutations in human prostate cancer. Cancer Res 50:6830-6832, 1990.
32. Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, Ware JL: Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 58:721-729, 1994.
33. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS: Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18 (submitted), 1996.
34. Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Chen L, Jay G: Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc Natl Acad Sci USA 91:11874-11878, 1994.
35. Webber MM: Normal, benign and malignant human prostatic epithelium: In vitro cell models for studies on the etiology, treatment, and prevention of benign and malignant human prostatic neoplasia. In Webber MM, Sekely LI (eds): "In Vitro Models for Cancer Research. Carcinoma of the Prostate and Testis." Vol. V. Boca Raton, FL: CRC Press, 1988, pp 25-103.
36. Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, Rhim JS: Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis 17:1641-1646, 1996.
37. Webber MM: Normal and benign human prostatic epithelium in culture. I. Isolation. In Vitro 15:967-982, 1979.
38. Liu XH, Wiley HS, Meikle AW: Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α) and epidermal growth factor (EGF)/TGF-α receptor. J Clin Endocrinol Metab 77:1472-1478, 1993.
39. Plymate SR, Loop SM, Hoop RC, Wiren KM, Ostenson R, Hryb DJ, Rosner W: Effects of sex hormone binding globulin (SHBG) on human prostatic carcinoma. J Steroid Biochem Mol Biol 40:833-839, 1991.
40. Zur Hausen H: Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 49:4677-4681, 1989.
41. Woodworth CD, Waggoner S, Barnes W, Stoler MH, DiPaolo JA: Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res 50:3709-3715, 1990.
42. Chen T-M, Pecoraro G, Defendi V: Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res 53:1167-1171, 1993.
43. McNicol PJ, Dodd JG: High prevalence of human papillomavirus in prostate tissues. J Urol 145:850-853, 1991.
44. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M: Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 52:5991-5996, 1992.
45. Tu H, Jacobs SC, Mergner WJ, Kyprianou N: Rare incidence of human papillomavirus type 16 and 18 in primary and metastatic human prostate cancer. Urology 44:726-731, 1994.
46. Sinclair AL, Noun AME, Oliver RTD, Sexton C, Dalgleish AG: Bladder and prostate cancer screening for human papillomavirus by polymerase chain reaction: Conflicting results using different annealing temperatures. Br J Biomed Sci 50:350-354, 1993.